Johnson & Johnson (JNJ) SEC Filings & 10K Form

$146.37
-2.16 (-1.45%)
(As of 12:27 PM ET)

Recent Johnson & Johnson SEC Filings

DateFilerForm TypeView
04/16/2024
11:16 AM
Johnson & Johnson (Filer)
Form 8-K/A
04/16/2024
6:06 AM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2024
4:05 PM
Contineum Therapeutics, Inc. (Issuer)
Johnson & Johnson (Reporting)
Johnson & Johnson Innovation - JJDC, Inc. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/10/2024
4:12 PM
Contineum Therapeutics, Inc. (Subject)
Johnson & Johnson (Filed by)
Form SC 13G
04/05/2024
4:29 PM
Johnson & Johnson (Filed by)
Shockwave Medical, Inc. (Subject)
Form DFAN14A
03/27/2024
8:48 AM
Johnson & Johnson (Subject)
National Legal & Policy Center (Filed by)
Form PX14A6G
03/13/2024
3:28 PM
Broadhurst Vanessa (Reporting)
Johnson & Johnson (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/13/2024
3:36 PM
Broadhurst Vanessa (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
6:42 AM
Johnson & Johnson (Filer)
Form ARS
03/13/2024
6:35 AM
Johnson & Johnson (Filer)
Form DEF 14A
03/13/2024
6:37 AM
Johnson & Johnson (Filer)
Form DEFA14A
03/13/2024
6:39 AM
Johnson & Johnson (Filer)
Form DEFA14A
03/06/2024
2:42 PM
CVRx, Inc. (Issuer)
Johnson & Johnson (Reporting)
Johnson & Johnson Innovation - JJDC, Inc. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2024
4:58 PM
Johnson & Johnson (Issuer)
Taubert Jennifer L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2024
4:54 PM
Decker Robert J (Reporting)
Johnson & Johnson (Issuer)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:12 PM
Johnson & Johnson (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/15/2024
4:23 PM
Ambrx Biopharma, Inc. (Subject)
Johnson & Johnson (Filed by)
Form DFAN14A
02/15/2024
3:53 PM
Decker Robert J (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:53 PM
Broadhurst Vanessa (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:53 PM
Forminard Elizabeth (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:53 PM
Duato Joaquin (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:53 PM
Hait William (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:53 PM
Fasolo Peter (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:53 PM
Johnson & Johnson (Issuer)
Schmid Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
5:36 PM
Johnson & Johnson (Issuer)
Wengel Kathryn E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
5:36 PM
Decker Robert J (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
5:36 PM
Johnson & Johnson (Issuer)
Schmid Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
5:36 PM
Duato Joaquin (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
5:36 PM
Johnson & Johnson (Issuer)
Swanson James D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
5:36 PM
Fasolo Peter (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
5:36 PM
Johnson & Johnson (Issuer)
Taubert Jennifer L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
5:36 PM
Forminard Elizabeth (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
5:36 PM
Johnson & Johnson (Issuer)
Wolk Joseph J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
5:36 PM
Hait William (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
5:36 PM
Broadhurst Vanessa (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
6:24 PM
Decker Robert J (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
6:24 PM
Broadhurst Vanessa (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
6:24 PM
Hait William (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
6:24 PM
Fasolo Peter (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
6:24 PM
Johnson & Johnson (Issuer)
Schmid Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
6:24 PM
Johnson & Johnson (Issuer)
Swanson James D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Mysterious Gold Leverage Just Announced (Ad)

World's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.

Find out what it is and see how you can get in with just a few dollars.
02/12/2024
6:24 PM
Forminard Elizabeth (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
6:25 PM
Johnson & Johnson (Issuer)
Wolk Joseph J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
6:25 PM
Johnson & Johnson (Issuer)
Wengel Kathryn E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
6:25 PM
Duato Joaquin (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
6:25 PM
Johnson & Johnson (Issuer)
Taubert Jennifer L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
11:55 AM
Johnson & Johnson (Subject)
McEvoy Ashley (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/09/2024
11:35 AM
Johnson & Johnson (Subject)
Taubert Jennifer L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/06/2024
3:24 PM
Johnson & Johnson (Subject)
McEvoy Ashley (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/02/2024
4:07 PM
BiomX Inc. (Subject)
Johnson & Johnson (Filed by)
Form SC 13G/A
02/02/2024
3:52 PM
CVRx, Inc. (Subject)
Johnson & Johnson (Filed by)
Form SC 13G/A
02/02/2024
3:32 PM
Johnson & Johnson (Filed by)
Johnson & Johnson (Filed by)
Nanobiotix S.A. (Subject)
Form SC 13G/A
01/30/2024
11:46 AM
Johnson & Johnson (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/29/2024
3:50 PM
Ambrx Biopharma, Inc. (Subject)
Johnson & Johnson (Filed by)
Form DFAN14A
01/24/2024
11:51 AM
Johnson & Johnson (Filed by)
Kenvue Inc. (Subject)
Form SC 13G
01/23/2024
6:45 AM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2024
4:08 PM
Ambrx Biopharma, Inc. (Subject)
Johnson & Johnson (Filed by)
Form DFAN14A
01/08/2024
4:22 PM
Ambrx Biopharma, Inc. (Subject)
Johnson & Johnson (Filed by)
Form DFAN14A
01/08/2024
7:22 AM
Johnson & Johnson (Filer)
Form DEFA14A
12/08/2023
3:33 PM
Johnson & Johnson (Issuer)
Woods Eugene A. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/07/2023
4:17 PM
HEWSON MARILLYN A (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
3:42 PM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2023
6:52 AM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/30/2023
3:30 PM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/27/2023
3:56 PM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2023
3:36 PM
Johnson & Johnson (Issuer)
Schmid Timothy (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/23/2023
3:48 PM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2023
6:33 AM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2023
3:36 PM
HEWSON MARILLYN A (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2023
6:46 AM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/25/2023
4:02 PM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/25/2023
3:53 PM
Johnson & Johnson (Reporting)
Kenvue Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2023
6:04 AM
Johnson & Johnson (Subject)
Form SC TO-I/A
08/23/2023
5:37 AM
Johnson & Johnson (Subject)
Form 425
08/21/2023
5:52 AM
Johnson & Johnson (Subject)
Form SC TO-I/A
08/21/2023
5:38 AM
Johnson & Johnson (Subject)
Form 425
08/18/2023
4:11 PM
Johnson & Johnson (Subject)
Form 425
08/17/2023
3:53 PM
Johnson & Johnson (Subject)
Form 425
08/17/2023
5:23 AM
Johnson & Johnson (Subject)
Form SC TO-I/A
08/16/2023
8:22 PM
Johnson & Johnson (Subject)
Form 425
08/16/2023
3:43 PM
Johnson & Johnson (Subject)
Form 425
08/15/2023
3:43 PM
Johnson & Johnson (Subject)
Form 425
08/14/2023
3:44 PM
Johnson & Johnson (Subject)
Form 425
08/11/2023
3:51 PM
Johnson & Johnson (Subject)
Form 425
08/04/2023
3:32 PM
Johnson & Johnson (Subject)
Form 425
08/03/2023
3:39 PM
Johnson & Johnson (Subject)
Form 425
08/03/2023
7:03 AM
Johnson & Johnson (Subject)
Form SC TO-I/A
08/01/2023
3:39 PM
Johnson & Johnson (Subject)
Form 425
07/31/2023
3:06 PM
Johnson & Johnson (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/28/2023
7:59 PM
Johnson & Johnson (Subject)
Form 425
07/27/2023
4:52 PM
Hait William (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
See this before next week's Fed meeting (Ad)

See this before next week's Fed Meeting Doc Eifrig just released a new video detailing "the perilous moment Americans are in right now." Angry voters, mounting government debt, and blood in the streets… But he's got a way out – a unique way to come out on top no matter who wins this presidential election. (Last time we shared this, it led to a 995% gain.)

Click here to see it.
07/27/2023
4:52 PM
Fasolo Peter (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2023
3:51 PM
Johnson & Johnson (Subject)
Form 425
07/24/2023
3:04 PM
Johnson & Johnson (Subject)
Form 425
07/24/2023
3:04 PM
Johnson & Johnson (Subject)
Form 425
07/24/2023
3:04 PM
Johnson & Johnson (Subject)
Kenvue Inc. (Filed by)
Form 425
07/24/2023
3:04 PM
Johnson & Johnson (Subject)
Form 425
07/24/2023
3:04 PM
Johnson & Johnson (Subject)
Form 425
07/24/2023
3:05 PM
Johnson & Johnson (Subject)
Form 425
07/24/2023
3:05 PM
Johnson & Johnson (Subject)
Form 425
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NYSE:JNJ) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners